1. Home
  2. AGIO vs STEL Comparison

AGIO vs STEL Comparison

Compare AGIO & STEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$28.09

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Stellar Bancorp Inc.

STEL

Stellar Bancorp Inc.

HOLD

Current Price

$37.71

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
STEL
Founded
2007
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
AGIO
STEL
Price
$28.09
$37.71
Analyst Decision
Buy
Buy
Analyst Count
8
2
Target Price
$38.88
$37.00
AVG Volume (30 Days)
856.8K
196.5K
Earning Date
04-29-2026
04-28-2026
Dividend Yield
N/A
1.61%
EPS Growth
N/A
N/A
EPS
N/A
0.53
Revenue
$43,011,000.00
$6,282,000.00
Revenue This Year
$76.75
$10.14
Revenue Next Year
$170.73
$4.65
P/E Ratio
N/A
$70.56
Revenue Growth
N/A
N/A
52 Week Low
$22.24
$26.30
52 Week High
$46.00
$40.21

Technical Indicators

Market Signals
Indicator
AGIO
STEL
Relative Strength Index (RSI) 47.91 57.07
Support Level $26.42 $36.95
Resistance Level $29.37 $38.10
Average True Range (ATR) 0.94 0.50
MACD 0.16 0.05
Stochastic Oscillator 61.05 80.32

Price Performance

Historical Comparison
AGIO
STEL

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

About STEL Stellar Bancorp Inc.

Stellar Bancorp Inc is a U.S. based bank holding company. Through its subsidiary, Stellar Bank, the company provides a diversified range of commercial banking services predominantly to small to medium sized businesses, professionals, and individual customers. Its offerings include different types of loans, such as mortgage loans, home equity loans, automobile loans, etc.; deposit products, such as checking accounts, commercial accounts, money market accounts, savings accounts, etc. and other banking services like mobile banking, debit cards, cash management and wire transfer services, letters of credit, and others.

Share on Social Networks: